Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
Juan José Jiménez-RiveraAndrea Álvarez-CastilloJorge Ferrer-RodríguezJosé Luis Iribarren-SarríasMartín Jesús García-GonzálezPablo Jorge-PérezLacalzada-Almeida JuanRosalía Pérez-HernándezJavier Montoto-LópezRafael Martínez-SanzPublished in: Journal of cardiothoracic surgery (2020)
Preconditioning with levosimendan, is a cost-effective strategy preventing postoperative low cardiac output in patients with moderate-severe left ventricular systolic dysfunction undergoing elective coronary artery bypass graft surgery.
Keyphrases
- coronary artery bypass
- left ventricular
- patients undergoing
- percutaneous coronary intervention
- heart failure
- hypertrophic cardiomyopathy
- acute myocardial infarction
- cardiac resynchronization therapy
- cardiac surgery
- mitral valve
- left atrial
- aortic stenosis
- ischemia reperfusion injury
- blood pressure
- oxidative stress
- high intensity
- early onset
- cerebral ischemia
- coronary artery disease
- acute coronary syndrome
- drug induced
- acute kidney injury
- atrial fibrillation
- aortic valve
- catheter ablation